Year |
Citation |
Score |
2017 |
Ma Z, Chalkley RJ, Vosseller K. Hyper-O-GlcNAcylation activates NF-κB signaling through interplay with phosphorylation and acetylation. The Journal of Biological Chemistry. PMID 28416608 DOI: 10.1074/Jbc.M116.766568 |
0.591 |
|
2014 |
Ma Z, Vosseller K. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. The Journal of Biological Chemistry. 289: 34457-65. PMID 25336642 DOI: 10.1074/Jbc.R114.577718 |
0.626 |
|
2014 |
Skorobogatko Y, Landicho A, Chalkley RJ, Kossenkov AV, Gallo G, Vosseller K. O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles. The Journal of Biological Chemistry. 289: 3602-12. PMID 24280219 DOI: 10.1074/Jbc.M113.512814 |
0.803 |
|
2013 |
Ma Z, Vosseller K. O-GlcNAc in cancer biology. Amino Acids. 45: 719-33. PMID 23836420 DOI: 10.1007/S00726-013-1543-8 |
0.571 |
|
2013 |
Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells. The Journal of Biological Chemistry. 288: 15121-30. PMID 23592772 DOI: 10.1074/Jbc.M113.470047 |
0.627 |
|
2013 |
Ma ZY, Skorobogatko Y, Vosseller K. Tandem lectin weak affinity chromatography for glycoprotein enrichment. Methods in Molecular Biology (Clifton, N.J.). 951: 21-31. PMID 23296521 DOI: 10.1007/978-1-62703-146-2_2 |
0.793 |
|
2012 |
Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nature Chemical Biology. 8: 393-9. PMID 22366723 DOI: 10.1038/Nchembio.797 |
0.793 |
|
2012 |
Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. The Journal of Biological Chemistry. 287: 11070-81. PMID 22275356 DOI: 10.1074/Jbc.M111.302547 |
0.511 |
|
2011 |
Zachara NE, Vosseller K, Hart GW. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit12.8. PMID 22045558 DOI: 10.1002/0471140864.Ps1208S66 |
0.679 |
|
2011 |
Zachara NE, Vosseller K, Hart GW. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 17.6. PMID 21732316 DOI: 10.1002/0471142727.mb1706s95 |
0.625 |
|
2011 |
Yuzwa SA, Yadav AK, Skorobogatko Y, Clark T, Vosseller K, Vocadlo DJ. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. Amino Acids. 40: 857-68. PMID 20706749 DOI: 10.1007/S00726-010-0705-1 |
0.793 |
|
2011 |
Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Adolf-Bergfoyle J, Nowak MG, Gong Y, Lippa CF, Vosseller K. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry. Amino Acids. 40: 765-79. PMID 20563614 DOI: 10.1007/S00726-010-0645-9 |
0.789 |
|
2011 |
Lynch TP, Jackson SR, Shahriari KS, Ferrer CM, Lazarus M, Walker S, Vosseller K, Reginato MJ. Abstract 1267: Metabolic sensor O-GlcNAc Transferase is a novel regulator of prostate cancer invasion and angiogenesis via regulation of FoxM1 Cancer Research. 71: 1267-1267. DOI: 10.1158/1538-7445.Am2011-1267 |
0.446 |
|
2011 |
Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Nowak MG, Gong Y, Lippa CF, Vosseller K. Erratum to: Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry Amino Acids. 42: 2529-2529. DOI: 10.1007/s00726-011-0896-0 |
0.462 |
|
2010 |
Vosseller K. O-GlcNAc and aging: C. elegans as a genetic model to test O-GlcNAc roles in type II diabetic insulin resistance. Aging. 2: 749-51. PMID 21068466 |
0.414 |
|
2010 |
Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 29: 2831-42. PMID 20190804 DOI: 10.1038/Onc.2010.41 |
0.524 |
|
2009 |
Francisco H, Kollins K, Varghis N, Vocadlo D, Vosseller K, Gallo G. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program. Developmental Neurobiology. 69: 162-73. PMID 19086029 DOI: 10.1002/Dneu.20695 |
0.574 |
|
2009 |
Tallent MK, Varghis N, Skorobogatko Y, Hernandez-Cuebas L, Whelan K, Vocadlo DJ, Vosseller K. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. The Journal of Biological Chemistry. 284: 174-81. PMID 19004831 DOI: 10.1074/Jbc.M807431200 |
0.802 |
|
2009 |
Vosseller K, Skorobogatko Y, Bryfogle JA, LaFerla FM, Vocadlo DJ, Tallent M. P4-228: O-GlcNAc regulation of hippocampal synaptic plasticity in wild type and 3xTg-AD mice Alzheimer's & Dementia. 5: P497-P497. DOI: 10.1016/J.Jalz.2009.04.694 |
0.761 |
|
2008 |
Chalkley RJ, Wells L, Vosseller K. Chapter 15 O-GlcNAc Proteomics: Mass Spectrometric Analysis of O-GlcNAc Modifications on Proteins Comprehensive Analytical Chemistry. 52. DOI: 10.1016/S0166-526X(08)00215-8 |
0.684 |
|
2007 |
Vosseller K. Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems. Proteomics. Clinical Applications. 1: 1351-61. PMID 21136635 DOI: 10.1002/Prca.200700323 |
0.386 |
|
2007 |
Akimoto Y, Hart GW, Wells L, Vosseller K, Yamamoto K, Munetomo E, Ohara-Imaizumi M, Nishiwaki C, Nagamatsu S, Hirano H, Kawakami H. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology. 17: 127-40. PMID 17095531 DOI: 10.1093/Glycob/Cwl067 |
0.607 |
|
2006 |
Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Molecular & Cellular Proteomics : McP. 5: 923-34. PMID 16452088 DOI: 10.1074/Mcp.T500040-Mcp200 |
0.698 |
|
2005 |
Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW. Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. The Journal of Biological Chemistry. 280: 32944-56. PMID 16027160 DOI: 10.1074/Jbc.M503396200 |
0.661 |
|
2005 |
Vosseller K, Hansen KC, Chalkley RJ, Trinidad JC, Wells L, Hart GW, Burlingame AL. Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol. Proteomics. 5: 388-98. PMID 15648052 DOI: 10.1002/Pmic.200401066 |
0.636 |
|
2003 |
Wells L, Vosseller K, Hart GW. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cellular and Molecular Life Sciences : Cmls. 60: 222-8. PMID 12678487 DOI: 10.1007/S000180300017 |
0.371 |
|
2002 |
Vosseller K, Sakabe K, Wells L, Hart GW. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Current Opinion in Chemical Biology. 6: 851-7. PMID 12470741 DOI: 10.1016/S1367-5931(02)00384-8 |
0.667 |
|
2002 |
Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Molecular & Cellular Proteomics : McP. 1: 791-804. PMID 12438562 DOI: 10.1074/Mcp.M200048-Mcp200 |
0.628 |
|
2002 |
Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proceedings of the National Academy of Sciences of the United States of America. 99: 5313-8. PMID 11959983 DOI: 10.1073/Pnas.072072399 |
0.523 |
|
2002 |
Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. The Journal of Biological Chemistry. 277: 1755-61. PMID 11788610 DOI: 10.1074/Jbc.M109656200 |
0.666 |
|
2001 |
Vosseller K, Wells L, Hart GW. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics. Biochimie. 83: 575-81. PMID 11522385 DOI: 10.1016/S0300-9084(01)01295-0 |
0.686 |
|
2001 |
Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine Analytical Biochemistry. 293: 169-177. PMID 11399029 DOI: 10.1006/Abio.2001.5132 |
0.676 |
|
2001 |
Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc Science. 291: 2376-2378. PMID 11269319 DOI: 10.1126/Science.1058714 |
0.694 |
|
Show low-probability matches. |